Our Journey
-
1994
Establishing of Tabuk Pharmaceuticals, located in Riyadh, Kingdom of Saudi Arabia
-
1994
Establishing the first production site in Tabuk, Kingdom of Saudi Arabia
-
1997
Expand our geographical presence to include the Algerian market
-
1999
Expand our geographical presence to include markets of United Arab Emirates, Kuwait, Oman, Bahrain, Qatar and Jordan
-
2004
Expand our geographical presence to include the Egyptian market
-
2005
Establishing a well-developed Corporate Research and Development center in Jordan
-
2006
Acquisition of Tabuk Pharmaceuticals by Astra Industrial Group (AIG) as a 100% owned subsidiary
-
2007
Establishing a regional office for the Middle East and North Africa in Cairo, Egypt
-
2010
Acquisition of Sigma Tau Sudan by Tabuk Pharmaceuticals to strengthen Tabuk Pharmaceuticals presence in North Africa
-
2015
Launching a state-of-art new production site in Dammam, Kingdom of Saudi Arabia to be the first ever site in the Kingdom to manufacture lyophilized injectables
-
2016
Launching a modern new production site in Blida, Algeria to strengthen Tabuk Pharmaceuticals presence in North Africa